EM Vivas · Mental health and behavioural emergencies
Behavioural emergency — organic first and the MSE
Clinical viva on medical screening, MSE domains, agitation pharmacology and MHA principles.
On this page
Study tools
Target exams
Interpretation
Reveal interpretationShowHide
Organic first: vitals including temperature, glucose, time course, focal neurology — confirm the screening-element list against local psychiatry-ED protocol; the held scoping review maps medical-screening practices (history-taking, vitals, examination, imaging, ECG) and notes society recommendations against routine blanket labs.[1]
MSE domains and sedation (examiners expect structure): appearance/behaviour, speech, mood/affect, thought form and content (include suicidal/homicidal ideation), perception, cognition, insight/judgement — de-escalate first; IM sedation per local agitation protocol with airway and monitoring ready. Held methamphetamine-agitation data: droperidol median 5 mg TAS 16 min, olanzapine median 10 mg TAS 16 min, midazolam median 5 mg TAS 13 min, lorazepam median 2 mg TAS 29 min; no difference in adverse events.[2] Confirm agent choice against local protocol; avoid IM olanzapine + IM benzo per local guidance.
[3]Legal: capacity assessment; if serious risk and statutory criteria met, complete Mental Health Act detention; document risks, least restrictive option, and medical treatments given under necessity where applicable — confirm detention specifics against local mental-health legislation.
References3ShowHide
- [1]Ünlü L, Griese JA, Minotti B, et al. Medical screening of adult psychiatric patients presenting to the emergency department. Annals of Emergency Medicine, 2026.PMID 42233919
- [2]Cole JB, DeVries PA, O'Flaherty JL, et al. Intramuscular droperidol, olanzapine, midazolam, or lorazepam to treat methamphetamine intoxication in the emergency department. Am J Emerg Med, 2026.PMID 41740194
- [3]Large MM, Nielssen O, Ryan CJ, Hayes R Mental health laws that require dangerousness for involuntary admission may delay the initial treatment of schizophrenia. Soc Psychiatry Psychiatr Epidemiol, 2008.PMID 18060340